Illumina Inc (NASDAQ:ILMN)

433.14
Delayed Data
As of Sep 23
 -1.39 / -0.32%
Today’s Change
267.10
Today|||52-Week Range
555.77
+17.06%
Year-to-Date
Biondo Focus Fund Buys NVIDIA Corp, BioCryst Pharmaceuticals Inc, Teladoc Health Inc, Sells ...
Sep 22 / GuruFocus News - Paid Partner Content
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?
Sep 15 / Zacks.com - Paid Partner Content
QVT Financial LP Buys 51job Inc, Allot, ViacomCBS Inc, Sells S&P 500 ETF TRUST ETF
Sep 20 / GuruFocus News - Paid Partner Content
3 Crash-Ready Stocks to Buy in September
Sep 14 / MotleyFool.com - Paid Partner Content
The 1 Stock I'd Buy Right Now
Sep 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close434.59
Today’s open436.06
Day’s range431.28 - 436.67
Volume1,050,867
Average volume (3 months)710,829
Market cap$65.6B
Data as of 4:00pm ET, 09/23/2021

Growth & Valuation

Earnings growth (last year)-34.53%
Earnings growth (this year)+42.72%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)-8.58%
P/E ratio83.0
Price/Sales16.91
Price/Book13.90

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+3.88+1.34%
GILDGilead Sciences+0.31+0.43%
TECHBio-Techne Corp+3.90+0.73%
----
Data as of 4:00pm ET, 09/23/2021

Financials

Next reporting dateOctober 26, 2021
EPS forecast (this quarter)$1.31
Annual revenue (last year)$3.2B
Annual profit (last year)$656.0M
Net profit margin20.25%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts